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Summary 
Peptides  derived  from HLA-Cw3  and HLA-A24  within region  170-179 differ by  a  single 
substitution, at position 173, and are both presented by the dass I major histocompatibility complex 
molecule H-2K  a for recognition by routine cytolytic T lymphocytes (CTLs). As a first approach 
to understand the way T cell receptors (TCRs) intact with the HLA peptides, we have analyzed 
the TCR selection by, and recognition of, the two HLA antigenic sites. First, we have compared 
the TCR repertoires selected by HLA-Cw3 and HLA-A24, not only by sequencing the TCRs 
carried by CTL clones isolated and grown in vitro, but also by analyzing the TCRs expressed 
in vivo by peritoneal exudate lymphocytes from immune animals. Second, we have compared 
the TCR crossrecognition of HLA-A24 by CTLs selected by HLA-Cw3 with that of HLA-Cw3 
by CTLs selected by HLA-A24. The combined analysis of TCR selection by and recognition 
of these two related HLA antigenic sites provides evidence that the TCR/3 junctional regions 
interact  with the amino-terminal part of the HLA peptides. 
C 
TLs recognize antigenic peptides  presented by class I 
MHC molecules (1, 2). The specificity of this recogni- 
tion is conferred by the TCR ot//~ (3, 4). Whereas the struc- 
ture of several class I MHC molecules, and that of a class 
I MHC-peptide complex, were determined by crystallographic 
studies (5), such information is not available  yet for the TCR. 
However, a model of the TCR ol/B tertiary structure was 
proposed,  based on its homology with Igs (6). In any case, 
experimental evidence is lacking so far to support a topology 
of class I MHC-peptide recognition by TCRs. 
We previously reported that DBA/2 mice could mount 
a CTL response towards two related antigens, HLA-Cw3 and 
HLA-A24, in the context of the same murine class I MHC 
molecule, H-2K  a, and that a fraction of the CTLs raised in 
response to either HLA antigen was not reactive to the second 
HLA antigen (7). The optimal synthetic peptides recognized 
by these specific CTLs, corresponding to the region 170-179, 
differ by a single nonconservative substitution at position 173 
and bind their common restriction element H-2K  d with a 
similar affinity (Table 1) (8--12). Regions 170-179 of the related 
HLA molecules A2 and A3 are identical  to HLA-A24 and 
can also be recognized by H-2Ka-restricted  CTLs (13). 
We recently showed that the TCRs carried by H-2K  a- 
restricted CTLs specific for the Cw3 170-179 peptide were 
very limited in primary structure (14). They were encoded 
by few germline gene segments: a single VB segment ORB10), 
a singleJo~ segment (Jc~pHDS58), few Vot segments (mainly 
Vc~3, 4, 8), and few J/~ segments (mainly J/31.2, 1.4, 2.3). 
Thdrjunctional CDR3 c~ and/3 loops also displayed limited 
diversity: a single length of nine and six amino adds, respec- 
tively, a conserved non-V-, non-J-encoded glydne amino acid 
at position 97 in the CDR3/~, and a high occurrence of non- 
J-encoded glycine or charged amino acids at positions 94 and 
95 in the CDR3 c~. 
As a first approach to understand the topology of interac- 
tion of TCRs with their class I MHC-peptide ligand, we 
have now taken advantage both of the single amino add differ- 
ence between the Cw3 and A24 antigenic peptides and of 
the existence within each of the two CTL responses to HLA 
antigens of a noncrossreactive CTL population. 
We first tested a large series of Cw3-selected CTL clones 
bearing TCRs of known primary structure for crossrecogni- 
tion of A24. We then determined the TCR repertoire selected 
by the A24 peptide,  not only by sequencing the TCRs car- 
ried by CTL clones isolated and grown in vitro, but also by 
analyzing the TCR repertoire used in vivo by peritoneal ex- 
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Cw3  R  Y  L  K  N  G  K  E  T  L 
A24  -  -  -  E  ...... 
The HLA-Cw3 and -A24 molecules differ at a single position (173) within 
region 170-179 (8). The HLA-A2 and -A3 molecules, as well as the recom- 
binant molecules 2.2/3.3 and 3.3/2,3, display the same amino acid se- 
quence as HLA-A24 (13). Both pepfides harbor the K  a binding motif 
(underlined)  (2,  11,  12) and bind equally well to K  d (not shown). 
udate lymphocytes (PELs) 1 from immune animals. Finally, 
we tested some of these A24-seleced CTL clones for cross- 
recognition of Cw3. Our findings provide evidence that the 
TCR 3 junctional regions interact with the amino-terminal 
part of the class I MHC-restricted HLA antigenic peptides. 
Materials and Methods 
CTL Clones and PELs.  The CTL clones used in this study are 
listed in Table 2. They were maintained in culture as described in 
the references. PELs were isolated and analyzed as previously de- 
scribed (14). 
Cell Staining and Cytolytic Assays.  The cell staining was per- 
formed as previously described, as were the cytolytic assays (14). 
Direct Sequencing of  PCR Products.  The cDNA PCR and direct 
sequencing were performed as previously described (14--17). 
Oligonucleotides.  The JB1.2 and JB1,4 primers will be reported 
elsewhere (Pannetier et al., manuscript in preparation). Sequences 
of the newly designed primers specific  for the Vc~T2.5-5 (18) and 
V~B6.2.16 subfamilies  (19) are CAGAAAACAGAGCCAAAGAC 
and  GAGACACCGTTGTTAAAGGC,  respectively. The  other 
primers were previously described (15). 
Results 
Crossrecognition of  A24 by CTL Clones Selected by Cw3.  We 
previously reported the TCR sequences of 37 independent 
H-2Ka-restricted CTL clones specific for the Cw3 170--179 
antigenic site (14; Casanova et al., manuscript in preparation). 
We have now tested 30 of them for crossrecognition of the 
same antigenic site within A24. 
As summarized in Fig. 1, where the TCR primary struc- 
tures are shown along with the peptide fine specificity, most 
anti-Cw3 CTL clones are affected by the substitution at po- 
sition 173. 11 dories do not recognize A24 at all, and 16 clones 
display an "intermediate" recognition profile of A24. Among 
the latter category, the patterns were in fact heterogeneous, 
as illustrated in Fig. 2. Only three dones appear to recognize 
A24 as well as Cw3. 
The usage of the only two variable segments of the TCR 
repertoire selected by Cw3, namely  J3 and Vcr  was not evenly 
distributed between crossreactive and noncrossreactive clones. 
1 Abbreviation used in this ~per: PEL, peritoneal exudate lymphocyte. 
The J31.4 and J32.3  segments were more frequent among 
noncrossreactive  (6/11)  than  crossreactive  (3/19)  clones, 
whereas the reverse trend was found for J31.2. The Vow3 sub- 
family was more frequent among noncrossreactive (5/11) than 
crossreactive (1/19) dories, whereas the reverse trend was found 
for Voe4 and Vol8. 
The amino acids occurring at two positions of the CDR3 
ol also showed some bias with respect to crossreactivity pat- 
tern. At position 95, many (11/19)  crossreactive clones ex- 
pressed a non-V-, non-J-encoded positively charged residue, 
whereas none of the 11 noncrossreactive ones did. The fre- 
quency of negatively charged residues at positions 94 in the 
CDR3 ol, mostly Vc~4 and Voe8 encoded, was higher among 
crossreactive (16/19) than noncrossreactive (6/11) CTL dones. 
An examination of the reactivity patterns of individual 
clones that share identical ol or 3  chains further illustrates 
this  uneven distribution  of TCR  structural  features,  and 
demonstrates that the pattern of A24 crossreaction cannot 
be attributed solely to either chain. Several sets of CTL clones 
displaying identical TCR 3 chains, but different reactivities, 
were found. Clones Cw3/4A3, HLAIG6, PEA1, and PEA34 
crossreact with A24, unlike PEA13, although they share the 
same TCR 3  sequence. Notably, the former clones are all 
Voe8 and their CDR3  ot contain a pair of complementary 
charges, while the latter clone is Vc~3 and its CDR oe con- 
tains only an acid charge. Similarly, clones Cw3/PEA30 and 
HLA1C8 share the same TCR 3 sequence and are both Vow4, 
but the former does crossreact and its CDIL3c~ contains a 
pair of opposite charges, whereas the latter does not cross- 
react and its CDR3oe only contains an acid residue. Finally, 
whereas the clone Cw3/C37 is VoeS, with a CDR3 ol con- 
taining two complementary charges, the clone HLA2D3 is 
Vow4, its CDR3 c~ contains no charged residue, and only the 
former clone crossreacts although they both display the same 
TCR 3  sequence. 
Conversely, CTL clones sharing an identical TCR o~ chain 
(although, rigorously, divergence in the Vo~ segment upstream 
of the region sequenced may exist),  but  differing in  fine 
specificity, were also found. Clones Cw3/1.1, HLA2A3, and 
PEA21 express the same TCR o~ chain, but only the latter 
does not crossreact with A24. Its TCR 3  differs from that 
of the two other clones in J3 segment usage 082.3 instead 
of J31.2  or J32.7). 
Thus, in the absence of any strict structure-function segre- 
gation, it is impossible to conclude from these data that any 
of these TCR regions confer or block crossrecognition of 
A24.  Rather, it appears  that crossrecognition of A24 does 
not depend on a single region of the TCR, since several regions 
of the o~/~ heterodimer correlate with the crossreactivity pat- 
terns. Moreover, the possibility remains that any of these TCR 
regions  may  contribute  to  the  crossreaction  pattern  by 
modulating the overall affinity of the complex, even by in- 
teracting with a region distinct from residue 173. Altogether, 
a firm conclusion in terms of topology of the ternary com- 
plex cannot be drawn from these first results alone. To inves- 
tigate further the contribution of each of these TCR elements, 
we next assessed the effect of the substitution at position 173 
found in A24 on the direct selection of a TCR repertoire. 
812  TCKs Selected by HLA-A24 in the Context of H-2K  d Table  2.  Origin of H-2Ka-restricted CTL Clones Selected by the HLA-A24  170-179  Antigenic Site Used in  This Study 
Mouse  Strain  Immunogen*  In vitro stimulation  CTL clones  Reference 
1  DBA/2  P815-A24  P815-A24  A24/10.1,  12.2  7 
2  DBA/2  P815-A3  P815-A3  A3/74.1,  72.2  10 
3  DBA/2  P815-A3/h~2m  P815-A3/hB2m  A3/IC1  This report* 
4  DBA/2  P815-A3/h32m  P815-A3/h32m  A3/IIC7  This report* 
5  DBA/2  P815-A3/h32m  P815-A3/h32m  A3/IIIC5  This report* 
6  FI(B10.D2  x  LG/Ckc)  P815-A3/h~2m  P815-A3/h/32m  A3/H2R2, H2R5  This report* 
7  FI(B10.D2  x  LG/Ckc)  P815-A3/h/$2m  P815-A3/hf12m  A3/C32b,  C46b, CS0b  This report* 
8  DBA/2  P815-A2  P815-A2  A2/25  13 
9  DBA/2  P815-A3  P815-A3  A3/63  13 
10  DBA/2  P815-2.2/3.2  P815-2.2/3.2  223/5,  14, 27  13 
11  DBA/2  P815-3.3/2.3  P815-3.3/2.3  332/1K,  2A, 2G  13 
12  DBA/2  P815-A24  P815-A24  A24/PEF1,  2, 4,  5, 8  This reports 
13  DBA/2  P815-A24  P815-A24  A24/PEG2  This reports 
The specificity  of the CTL clones  from mice 1, 2, and 8-13 was established  by recognition  of the transfectant  cell line P815-A24 (6) and was further 
documented with P815 cells pulsed with synthetic  peptides corresponding to the region 170-182 (for clones A24/12.2 and A3/74.1) or 170-179 
(all other clones) of the HLA-A24 molecule. The specificity  of CTL clones from mice 3-7 was established  by recognition  of P815 cells transfected 
with HLA-A3, whose sequence in the 170-179 region is identical  to that of HLA-A24. The H-2K  d restriction  of the CTL clones  mice 3-7 is based 
on antibody  blocking experiments, and that of clones from mice 1, 2, and 8-13 is presumed from recognition of A24 peptides, which are known 
to bind to H-2K  d. 
* P815-A24 indicates a P815 mastocytoma  cell line transfected  with the HLA-A24  gene (6), and P815-A2, A3, 2.2/3.2, and 3.3/2.3 indicate P815 
cell lines transfected  with natural or recombinant genes encoding proteins that share A24 sequence within region 170-179 (13). P185-A3/h/32m 
indicates a P185 cell line transfected  with the HLA-A3 gene and the human 32m gene (Barra et al., unpublished results). 
* These clones were isolated as described in references 6 and 10. 
s These clones were derived by limiting dilution of CD8 + PELs, from animals immunized intraperitoneally  with P815-A24 transfectant  cells. 
TCRs Carried by CTL Clones Selected by A24.  We ana- 
lyzed a collection of 26 H-2Ka-restricted  CTL clones specific 
for the site 170-179 of HLA-A24 that were judged to be in- 
dependent based on differences either in TCR nucleotide se- 
quence or in the animal of origin (Table 2). 
The TCR repertoire selected by A24 appears to be in many 
respects similar to the TCR repertoire selected by Cw3 (Figs. 
3 and 4). In particular, most CTL clones express TCRs bearing 
the  V~10  and JotpHDS58  segments.  However,  the A24- 
sdected TCR repertoire also seems to be broader, as illus- 
trated by the presence of additional structures in most regions 
of the ot//$ heterodimers. 
When precisdy compared with the TCRs from the Cw3- 
selected TCR repertoire, the TCRs selected by A24 dearly 
fall in three categories.  The first group (I) includes 11 TCRs 
that are indistinguishable from those found in the Cw3-sdected 
TCR repertoire. They express the V/$10 segment, a J/$1.2, 
2.3,  1.1, or 2.7 segment, a Vot8, 4, 3,  or 5 segment, and 
the JotpHDS58  segment. They display a CDR3 ot length 
of nine amino acids, a CDR3/3 length of six amino acids, 
a glycine or a charged residue at positions 94 and 95 in the 
CDR3 ot, and a glycine at position 97 in the CDR3/~. The 
resemblance with the HLA-Cw3 TCR repertoire is such that 
six and four of these A24-selected  CTL clones express TCR 
/~ and ot chains, respectively, identical to some of those found 
among Cw3-selected CTL clones.  The other TCRs differ 
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from the Cw3-selected TCRs either by few conservative sub- 
stitutions in either of the CDR3 or by the usage of a distinct 
member of the same Vot subfamily. 
The second group (II) includes six TCRs, which differ from 
the CW3-reactive TCRs by only a single criterion.  Five clones 
express a CDR3/3 length of 10 amino acids, all of which 
are V/$10-J/$1.4. In contrast, all V/$10-J/$1.4 CDR3 loops in 
the anti-Cw3 TCR repertoire were of six amino acids. In 
addition, one clone uses the J/$2.4 segment, which was not 
found in the Cw3-reactive TCR repertoire. Among the TCRs 
of group II, one TCR ot chain is identical to one found in 
the Cw3 repertoire, and the others differ by only a few con- 
servative substitutions in the CDR3 or by the usage of a dis- 
tinct member of the same Vot subfamily from the anti-Cw3 
TCR repertoire. 
The third group (III) includes nine clones,  in which at 
least two changes were observed  when compared with the 
TCR features characteristic of the response to Cw3. Remark- 
ably, in all cases at least one of these changes concerns the 
TCR/3 junctional region, again either in the usage of different 
J/~ segments 0/$2.4,  1.3,  2.5,  2.1),  or of different CDR3 
lengths (V/$10-J/$1.4 loops of 10 amino acids).  Additional 
changes can affect every part of the heterodimers: V/~ seg- 
ment usage, CDR3 3  length, lack of glycine at position 97 
in the CDR3/~,  Vot  subfamilies  usage, CDR3 ot length, 
and Jot  segment usage. CTL  clone  TCR  ~  TCR 
V~  FW  CDR3  FW  FW  CDR3  FW  Ju 
CW3/I. 1 
Cw3/Cas20 
Cw3/2cl 
CW3/pED5 
Cw3/pFJtl 4 
CW3/PE~23 
Cw3/Ca82 
CW3/4A3 
CW3/HLAIG6 
Cwa/PEJLI 
Cw3/PEAI 3 
Cw3/pEJt34 
Cw3/C37 
Cw3/~D3 
Cwa/HLAlC8 
Cw3/PE~0 
Cw3/10.1 
Cw3/pEA9 
CW3/A8 
Cw3/Casl 
Cw3/pEA21 
cwa/701.1 
cw3/56.1 
cw3/2c3 
Cw3/PED2 
Cw3/Cas7 
CW3/1B4 
Cw3/SB8 
CWa/ELA2A3 
CW3/CaeI5 
99 
I 
I0  CAS  S  L  G  S  D  Y  TFG 
I0  CAS  S  L  G  S  D  u  TFG 
10  CAS  S  L  G  S  D  Y  TFG 
I0  CAS  S  L  G  S  D  Y  TFG 
i0  CAS  S  Y  G  S  D  X  TFG 
i0  CR~  S  Y  G  S  D  Y  TFG 
I0  CAS  S  F  G  S  D  Y  TFG 
I0  C~  S  R  G  S  D  Y  TPG 
I0  CAS  S  R  G  S  D  Y  TFG 
I0  CJLS  S  R  G  S  D  Y  TPG 
I0  CAS  S  R  G  S  D  Y  T~G 
10  CAS  S  R  G  S  D  Y  TFG 
I0  CAS  S  Y  G  T  D  Y  TFG 
I0  CAS  S  Y  G  T  D  Y  TFG 
I0  C~  S  Q  G  T  D  Y  TFG 
I0  CAS  S  Q  G  T  D  Y  TFG 
I0  CAS  S  T  G  F  D  T  TFG 
i0  CAS  S  Q  G  P  D  Y  TFG 
i0  CAS  S  L  G  E  T  L  TFG 
i0  CAS  S  L  G  E  T  L  YFG 
I0  C,  AS  S F  G E  T  L  YFG 
I0  CAS  S  Y  G  E  T  L  YFG 
i0  CAS  S  W  G  E  T  L  YFG 
I0  CAS  S  Y  G  E  R  L  FFG 
I0  CAS  S  Y  G  E  R  L  FFG 
i0  C~  S  F  G  E  R  L  FFG 
10  CAS  S  Q  G  E  R  L  FFG 
I0  CAS  S  K  G  V  M  G  ~G 
i0  CJ~S  S  S  GRVE  ~G 
I0  CAS  S  F  G  Q  2  V  FFG 
J~  ,ca 
1.2  8.p71 
1.2  S.p71 
1.2  4.TA65 
1.2  8.F3.6 
1.2  8.p71 
1.2  4.PJR-25 
1.2  8.F3.2 
1.2  4  .P/R-25 
1.2  4.1G6 
1.2  4.PJR-25 
1.2  8.F3.6 
1.2  4.PJR-25 
1.2  8.F3.6 
1.2  3.A8 
1.2  4.3 
1.2  4  ,PJR-25 
1.2  I,TA84 
1.2  4,)~-13 
2.3  3,A8 
2.3  5,M~A 
2.3  8.p71 
2.3  3 .AR-5 
2.3  3.AR-5 
1.4  5.~A 
1.4  3.AR-5 
1.4  8.F3.2 
1.4  3.AR-5 
2.7  4.3 
2.7  8.p71 
1.1  8.p71 
94 
J 
CA~  S  E  G  G  P  A  S  A  L  TFG  pHDS58 
CAL  S  D  Q  G  F  A  S  A  L  TFG  pHDS58 
C2~L  S  D  R  G  F  A  S  A  L  TFG  pHDS58 
C~  S  D  Q  G  F  A  S  A  L  TFG  pHDS58 
CAL  S  D  R  G  F  A  S  A  L  TFG  pHDS58 
CAL  S  D  R  G  F  A  S  A  L  TFG  p41DS58 
CJtL  S  D  R  G  F  A  S  A  L  TFG  pHDS58 
CAL  S  D  R  G  F  A  S  A  L  TFG  pHDS58 
CAL  5  D  R  G  F  A  S  A  L  TFG  pHDS58 
CAL  S  D  R  G  F  A  S  A  L  TFG  pBDS58 
CAL  S  D  Q  G  F  A  S  A  L  TFG  pHDS58 
C~  S  D  R  G  F  A  S  A  L  TFG  pIKDS58 
CAL  S  D  R  G  F  A  S  A  L  TFG  pBDS58 
CAV  S  A  G  G  F  A  S  A  L  TFG  pHDS58 
CAL  G  D  P  G  F  A  S  A  L  TFG  pBDS58 
C~%L  S  X  G  G  F  A  S  A  L  TFG  pE~S58 
CAV  S  E  H  G  F  A  S  A  L  TFG  pHDS58 
CAL  S  D  R  G  F  A  S  A  L  TFG  pHDS58 
CAV  S  M  G  G  F  A  S  A  L  TFG  pHDS58 
CAV  S  A  G  G  F  A  S  A  L  TFG  pHDS58 
CAL  S  E  G  G  F  A  S  A  L  TFG  p~$58 
CA1.  T  Q  T  G  F  A  S  A  L  TFG  pHDS58 
CAL  S  A  T  G  F  A  S  A  L  TFG  pHDS58 
CAV  S  E  G  G  F  A  S  A  L  TFG  p~$58 
CAL  S  A  T  G  F  A  S  A  L  TFG  pHDS58 
CAL  S  E  R  G  F  A  S  A  L  TFG  pHDS58 
C~  S  A  T  G  F  A  S  A  L  TFG  pHDS58 
CAL  G  E  G  G  F  A  S  A  L  TFG  pHDS58 
CAL  S  E  G  G  F  A  S  A  L  TFG  pRD858 
CAL  S  D  G  G  F  A  S  A  L  TFG  pRDS58 
Figure  1.  TCR c~ and/3 chains carried by Cw3-selected CTL clones and their crossrecognition of A24. The nucleotide sequences and the deduced 
amino acid sequences  of the TCR a  and/3 junctional regions carried by 20 of the 30 anti-Cw3 CTL clones represented here were already published 
(14). The TCR sequences  of the remaining 10 clones (Cw3/PEA,  PED), all derived from PELs, will be reported elsewhere with those of additional 
anti-Cw3 CTL dories also derived from PELs. The V/~ Vo4 J/3, and Jc~ segments are represented. The deduced amino acid sequences of the junctional 
and hypervariable region, putatively  CDR3;like, are reported (in single-letter amino acid code) according  to reference 6. The presumed Ig-like loop, 
designated  CDR3 for convenience,  is putatively  supported  by two framework branches (FW), which are also reported here. The key Cys residue is 
at positions 90 and 92 in the o~ and/3 chains,  respectively.  The TCR oe junctional region of CTL clone Cw3/PEA30  could not be unambiguously 
determined.  All CTL clones recognize the HLA-Cw3  170-179  antigenic site ([-1)~ Levels of crossrecognition of the A24  170-179  antigenic site are 
indicated:  (El) recognition of A24 as well as that of Cw3; (k~) intermediate  recognition; or (JJ) no recognition. Clones Cw3/AS, Casl, Cas20,  1.1, 
10.1, 701.1,  PED2, and PED5 were tested for recognition of the Cw3 and A24 170-179 synthetic peptides  and for recognition of the P815-Cw3 and 
A24 transfectant cells.  Clone Cw3/56.1  was tested for recognition of P815-Cw3  and A24 transfectant cells.  Clones Cw3/PEA1,  9,  13,  14,  21,  23, 
30, and 34 were tested for recognition of the HLA-Cw3 and A24 170-179 peptides,  and for recognition of the P815-Cw3 and A24 transfectant cells. 
Clones Cw3/HLA1G6, HLA2D3, HLAIC8, and HLA2A3 were tested for recognition of the HLA-Cw3 and A24 170-179 peptides, and clone HLA2D3 
was further  tested on P815-Cw3  and A24 transfectant  cells.  Clones Cw3/Cas2,  Cas7,  Cas15,  C37,  2C1, 4A3,  1B4,  5B8,  and 2C3 were tested for 
recognition of the HLA-Cw3 and A24 peptides.  E/T ratios or peptide concentrations were titrated to evaluate the relative recognition of transfectants 
or peptides,  respectively. 
When compared with the Cw3-selected TCRs that did 
not crossrecognize  A24, it appears that A24-selected TCRs 
display paradoxically a similar distribution in terms of Vc~3 
subfamily usage and charged amino acid composition at po- 
sitions 94 and 95 of the CDR3  cr 
The frequency of Voe3 among A24-selected clones (6/26) 
is similar to that  of Cw3-selected clones (6/30),  although 
of the latter Voe3 clones,  most did not crossrecognize  A24. 
The frequency of negatively charged residues in the CDR3 
c, at position 94 is also lower (8/26 vs. 22/30), and even lower 
is the frequency of positively charged residues at position 95 
(5/26 vs. 12/30), although again the negatively charged res- 
idue at position 94, and even more,  the positively charged 
residue at position 95, were found to be less frequent among 
the anti-Cw3 clones that did not crossrecognize  A24. 
These results suggest that the Vo~ usage and the CDR3 
cx composition in charged residues would not be critical for 
recognition of position 173 of the HLA peptides, but rather 
would contact  another region, possibly contributing to the 
crossreaction patterns observed among Cw3-selected clones 
tested for crossrecognition of A24 by modulating the overall 
affinity of the TCRs for their ligand. 
In contrast, among the A24-selected CTL clones, the usage 
ofJ/32.3 is reduced (1/26), and that of VB10-J31.4 loops of 
six amino acids is abolished, in agreement with the previous 
observation  that within the Cw3-selected repertoire,  their 
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Figure  2.  Crossrecognition  of  A24 by a set ofCwb-selected  CTL clones. 
Three Cwb-selected  CTL clones, Cw3/10.1, AS, and PED5, were tested 
for recognition either of P815 cells transfected with the HLA-Cw3 (O) 
or A24 (0) genes (left), or of P815 (H-2  d) target cells pulsed with HLA- 
Cw3 (O) or A24 (0) 170-179 peptides (right). Lysis  of control P815 cells 
without peptide is also shown (dashed lines). 
frequency was lower among the clones that  did not cross- 
recognize A24 than  among  those that  did. 
These resuhs in turn suggest that the TCK fl junctional 
region is critical for recognition of position 173.  Neverthe- 
less, the differences observed in the TCK repertoires selected 
by Cw3 and A24 may result either from an indirect effect, 
due to antigen-independent selective processes, or from differ- 
ences in the antigen-driven  selection, directly related to the 
MHC/antigenic peptide recognition.  In an attempt  to dis- 
criminate between the two hypotheses, we then tested A24- 
reactive CTL clones of known TCK primary structure for 
recognition  of HLA-Cwb. 
Crossrecognition of Cw3 by CTL Clones Selected by A24.  We 
tested 17 independent A24-selected CTL clones for crossrecog- 
nition of Cwb. Three clearcut categories emerged from these 
data, summarized in Fig. 4 and illustrated for two clones in 
Fig.  5.  Four clones recognized Cw3 as well as A24.  Two 
clones displayed an "intermediate pattern" of crossreactivity. 
11 clones were found to be completely negative for cross- 
recognition  of the Cw3 antigen. 
All clones that crossreact equally well with Cw3 bdong 
to the group I of TCK structures,  i.e.,  the group of TCKs 
most similar, when not identical, to those expressed by Cwb- 
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reactive CTL clones. The two clones with an intermediate 
reactivity, A3/74.1  and A24/12.2,  belong to groups I and 
III, respectively. The clone A3/74.1 bears the Jr1.1 segment 
and has therefore been classified  in group I.  However, this 
segment was found in only 2 of 37 Cwb-selected CTL clones, 
which may in part  explain  the somewhat lower crossreac- 
tivity of A3/74.1.  Among the remaining  11 clones that do 
not recognize at all the Cw3 sequence, only one belongs to 
the group I, 223/27, and this CTL clone not only again bears 
the jr1.1 segment, but also does not express any acid residue 
in the CDK3 due to extensive trimming  of the J~1.1 seg- 
ment.  Of the remaining  10 clones, four belong to group II 
and six to group III. 
Two CTL clones, 332/1K and A3/63, were found to ex- 
press an identical TCK chain,  and the comparison of their 
crossreactivity supports our previous conclusions. These two 
clones bear identical TCK ot chains, but whereas 332/1K cross- 
recognizes Cw3 as well as A24, A3/63 does not crossreact 
at all. 
Thus,  in contrast to the lack of strict structure-function 
correlation previously observed among the Cwb-selected CTL 
clones tested for crossrecognition of A24, a clear-cut segre- 
gation can be seen between the TCR fl junction  primary 
structure of A24-selected CTL clones and their crossrecog- 
nition of Cwb. The A24-selected CTL clones whose TCR.s 
differ from those carried by Cwb-selected CTL clones do not 
crossrecognize CWb, and the TCR differences take place at 
least, and often only, in the TCR fl junctional region. There- 
fore, these data point towards a role of this region for recog- 
nition  of position  173. 
TCRs Expressed In  Vivo by PELs from  Cwb- and A24- 
immunized Mice.  To rule out any bias in vitro during the 
isolation of this  set of CTL clones, or any bias due to an 
insufficient number of CTL clones analyzed, we then com- 
pared the TCR repertoire used in vivo in response to Cw3 
and A24. 
PELs were harvested after intraperitoneal  immunization 
with  P815-Cw3 and P815-A24 transfectant  cells,  and ana- 
lyzed as previously described (14). They displayed specific cyto- 
lytic activity without any stimulation in vitro (not shown). 
The proportion of Vfll0 among CD8 cells was significantly 
increased, indicating that the Vfll0 dominance observed on 
CTL clones also occurred in vivo (not  shown).  However, 
among A24-selected PELs, the higher variation of the Vfll0 
percentage among individuals, as well as the somewhat lower 
percentage on average than that found among Cwb-selected 
PELs, were compatible with the finding that clones expressing 
other Vfl segments may occasionally be selected by A24, as 
was the Vfll5 CTL clone PEG2,  derived from one mouse 
in which no Vfll0 increase was observed. 
To analyze the TCR response in more detail, a first cDNA 
PCR with a Vfll0 and a jr1.2 pair of primers was performed 
on the Cwb- and A24-specific PELs, and the product was 
directly sequenced with the Jr1.2 primer. As shown in Fig. 
6,  the product was not only dearly readable,  indicating  a 
homogeneity of the TCRs bearing these two segments, but 
also encoded a CDR3 of the same length as that of Cwb- 
or A24-reactive CTL clones known to express Vfll0-Jfll.2 A  TCR  ~  =DMAm 
CT5  clone  V~ 
A3/CS0b  8.F3.4 
A3/ICI  8.F3.4 
A3/IIIC5  8.F3.4 
A24/PEF8  8.F3.4 
22315  8.p71 
223127  8.p71 
A24/PEF5  8.p71 
223114  8.F3.6 
A3/c32b  8.F3.6 
332/1K  3.A3/63 
A3/63  3.A3/63 
A3/IIC7  3.3 
A3/74.1  3.A8 
A3/H2R2  3.2 
A3/C46b  3.C9 
A2/25  4.BDFLII 
332/2A  4.PJR25 
A24/PEFI  5.MDA 
A24/PEG2  5.MDA 
A24/PEF2  T2.5-5 
A24/10.1  T2.5-5 
332/2G  T2.5-5 
A24/12.2  I0,I09S 
A3/H2R5  10,FNI-18 
A3/72,2  13.2 
A24/PEF4  6.~3 
B  TCR  ~  GDMAm 
CTL  clone  V~ 
A3/C32b  10 
A3/ICI  10 
332/IK  10 
A3/IIC7  i0 
332/2A  i0 
A3/C46b  i0 
A24/PEFI  I0 
A24/I0.I  i0 
A3/63  I0 
332/2G  i0 
A3/74.1  10 
223/27  I0 
A24/PEF2  i0 
A3/H2R2  10 
A24/PEF8  10 
A24/PEF4  i0 
A24/12.2  10 
A3/IIIC5  10 
A2/25  I0 
223/5  10 
223/14  I0 
A3/H2R5  I0 
A24/PEF5  i0 
A3/72.2  1 
A3/CS0b  8.3 
A24/PEG2  15 
...TGT  GCT TTG  AGT  CAT GGG  GGC TTT GCA AGT GCG CTG  ACA TTT GGA... 
￿9  .TGT  GCT TTG AGT  GAA GGG GGC TTT GCA AGT  GCG CTG ACA TTT  GGA... 
..  TGT  GCT TTG AGT  GAA GGG GGC TTT GCA AGT GCG CTG  ACA TTT GGA... 
￿9  .TGT  GCT TTG AGT  GAG GG~  GGC TTT GGA AGT GCG CTG ACA TTT  GGA... 
￿9  .TGT GCT TTG AGT  AAG ACA GGC TTT GCA AGT GCG CTG ACA TTT GGA.,. 
￿9  .TGT GCT TTG AGT  GAC AAG  GGC TTT GCA AGT  GCG CTG  ACA TTT GGA... 
￿9  .TGT  GCT TTG  AGT  GTC GGA  GGC TTT GCA AGT GCG CTG  ACA TTT  GGA... 
..  TGT  G~T CTG AGT  CCT GGG GC,  C  TTT GCA AGT GCG CTG  ACA TTT GGA... 
￿9  .TGT  GCT CTG AGT  GAA GGG GGC TTT  GCA AGT GCG CTG ACA TTT  GGA. ,. 
￿9  .TGT  GCT GTG AGC GCG GGA GGC TTT GCA AGT  GCG CTG ACA TTT  GGA.,. 
..  TGT  GCT GTG AGC GCG GGG  GC,  C  TTT GCA AGT GCG CTG  ACA TTT  GGA.,. 
￿9  .TGT  GCT GTG AGC  GCG CGG  GGC TTT GCA bJGT GCG CTG  ACA TTT  GGA. ,. 
￿9  .TGT  GCT  CTG AGC ATG GGA GGC TTT GCA AGT GCG CTG  ACA TTT GGA.,. 
..TGT  GCT GCG AGG CCC AGA GGC TTT C,  CA AGT GCG CTG  ACA TTT  GGA... 
...  TGT GCT  GTG  AGC GCG GGG  C~C TTT GCA AGT GCG CTG  ACA TTT  GGA... 
,. .TGT  GTT CTG GGT  CAT CGG GGC TTT  GCA AGT  GCG CTG  ACA TTT GGA. .. 
.. .TGC  GCT CTG AGT  GAA AGA GGC TTT GCA AGT GCG CTG  ACA TTT GGA... 
., .TGC GCA GTC AGT  GCG GGA GGC TTT  GCA AGT GCG CTG  ACA TTT  GGA... 
.. .TGC GCA GTC AGT  GGG GGC TTT GCA AGT  GCG CTG ACA TTT GGA... 
.. .TGT GCA GCA AGC ATG GCA GGC TTT GCA AGT GCG CTG  ACA TTT  GGA... 
￿9  .TGT  GCA GCC TCG  GGG GGC TTT GCA AGT  GCG CTG  ACA TTT GGA,.. 
..TGT GCA GCA AGC GGG GC,  C  TTT  GCA AGT  GCG CTG ACA TTT  GGA.,. 
￿9  .TGT  GCT CCT GCG  CAG ACA GGC TTT  GCA AGT GCG CTG  ACA TTT  GGA... 
￿9  .TGT GCT  ATG GAA CGT GGG GGG GGC TTT  GCA AGT GCG  CTG ACA TTT  GGA... 
￿9  .TGT  GCT GTC ACG  GGT TAC CAG AAC TTC TAT TTT  GGG.., 
￿9  .TGT  ArC CTG AGT  AGA GGT TCA GCC TTA GGG AGG CTG  CAT TTT GGA... 
￿9  .TGT  GCC AGC AGC TTG GGA TCC GAC TAC ACC TTC 
￿9  ,TGT  GCC AGC AGC TTT GGC TCC GAC TAC ACC TTC 
￿9  ￿9  GCC AC,  C  AGC  CAG GGG TCC GAC TAC ACC TTC 
.,  TGT  GCC AGC AGC TAC QGC TCC GAC TAC ACC TTC 
.,  TGT  GCC AGC AGC TAC GGC TCC GAC TAC ACC TTC 
.,  TGT  GCC AGC AGC TAT GGA CA(= GAC TAC ACC TTC 
￿9  .TGT  GCC AGC AC,  C  TTC GGC CCC GAC TAC ACC TTC 
￿9  .TGT  GCC AGC AGC  CTA GGG  AAC  ACC TTG TAC TTT 
..  TGT GCC AGC AGC ACA GGA AAC ACC TTG TAC TTT 
￿9  .TGT  GCC AGC AGC TTC GGA AAC  ACC TTG TAC TTT 
..  TGT  GCC AGC AGC TTG GGA CAA GAA GTC TTC TTT 
￿9  .TGT  GCC AGC AGC TTT GGA CAG GGA GTC TTC TTT 
￿9  .TGT  GCC AGC AGC  TTT GGA AAT  ACG CTC TAT  TTT 
￿9  .TGT  GCC AGC AGC TTT GGG GAA ACG CTG TAT TTT 
￿9  .TGT  GCC AGC AGC  TCC GGA CAG  ACG GAG TAC TTC 
￿9  .TGT  GCC AGC AGC CGG GAC AAC CAA GAC ACC CAG 
..  TGT  GCC AGC AGC CTC GGG ACA GGG AAC AAC GAA 
￿9  .TGT  GCC AGC AGC  TAT GGG ACA GGG ACC AAC GAA 
￿9  .TGT GCC AGC AGC TTC GGG ACA ~G  AAC AAC GAA 
￿9  .TGT  GCC AGC AGC  TCC GGG ACA GGG GAA AGG GAA 
,.  TGT  GCC AGC AGC TTC GGG ACA GGG GAA AAC GAA 
￿9  .TGT  GCC AGC AGC GTC GGG ACA GGG CCC AAC GAA 
￿9  .TGT  GCC AGC AGC ACC GGG ACA GGG ACC AAC GAA 
￿9  .TGT  GCC AGC AGC CAA GCT GGG TAT GAA CAG TAC 
,.TGT  GCC AGC AGT  ACC 
., .TGT  GGT GCT  CCC GAG 
GGC.. 
GGC.. 
GGC.. 
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Figure  3.  TCR ~ and ~ eDNA 
junctional nucleotide  sequences of 
A24-selected CTL clones. (A) TCR 
c~junctional sequences. The nomen- 
clature for the V~ subfamilies fol- 
lows that of references 3, 29, and 
30. Here, the Vc~ subfamily is sepa- 
rated from the Vo~ gene segment by 
a period. The Vo~ gene segments are 
named according to their original 
description:  from  references  31 
(Vol5.MDA, Vcc8.p71, Vod0.FN1- 
18), 32 (Vc~8.F3.4, Vc~8.F3.6), 25 
(Vc~3.2, Vcc3.3), 33 (Vcz4.BDFLII), 
34 (Vcc4.PJR-25), 35 (Vod0.109S), 
36  (Vod3.2),  37  (V~3.C9),  14 
(Vc~3.AS), 18 (VolT2.5-5), and 38 
(Vc~6.~3), and this report (Vc~3.A3/ 
63). Due to partial sequencing, the 
Vcr segment identification is only 
putative. The partial  sequence of the 
Vc~3.A3/63 gene segment is avail- 
able upon request. All other  seg- 
ments but one are 100% identical 
at the nucleotide level to the pub- 
lished ones in the region sequenced, 
namely  downstream  of  the  Vo~ 
primer used for PCR and sequence. 
The Vol3.C9 gene segment partial 
sequence in CTL clone A3/C46b 
is identical to that  of CTL clone 
Cw3/1Fll (14), differs by a single 
base substitution from the original 
sequence, and is available upon re- 
quest.  The VotT2.5-5 partial se- 
quence is identical to the one previ- 
ously referred to as VerST.J3 (15). 
The Jc~pHDS58 gene segment  is 
from  references  39  and  40,  the 
J~TA65 is from reference 29, and 
the Jcr  is from reference 41. 
(/3) TCR B eDNA junctional se- 
quences. The nomenclature for the 
V/3 gene segments  follows  that of 
references 3 and 42-45. The VB1, 
V/iS.3, VB10, and V~15 sequences 
were  originally  reported in refer- 
ences 46,  42,  47,  and 43,  respec- 
tively.  The J~  gene segments  se- 
quences are from references 48 and 49, except JB1.4, which is from reference 15. Unambiguously assigned DB gene segments (50,  51) are underlined. 
These sequences are available from EMBL/GenBank/DDBJ  under accession numbers X70709-X70763. 
TCRs. As a control, the fragments amplified from LNs of 
nonimmunized mice were not readable at all, reflecting  the 
extensive diversity of VB10-JB1.2 junctions among unselected 
lymphocyte populations. 
Moreover, the apparent distinction between the TCR reper- 
toires  from CTL clones selected by HLA-Cw3 and HLA- 
A24, in terms of length of the V/310-J/31.4 CDR3, was also 
evident in vivo, since PELs from Cw3- or A24-immunized 
mice displayed V/310-J#81.4 loops of mutually exclusive lengths 
of 6 and 10 amino acids, respectively  (Fig.  6). Thus, a dis- 
tinctive feature of the TCR ~ junctional region repertoire, 
obtained from the comparison of a series of Cw3- and A24- 
selected CTL clones isolated and grown in vitro, was found 
to be relevant in vivo. 
These findings support  the conclusions drawn from the 
analysis of CTL clones isolated and grown in vitro, and indi- 
cate that the TCR B junctional region may be critical in rec- 
ognition of position  173 of the HLA peptides  in vivo. 
Discussion 
For the CTL clones selected either by Cw3 or A24 that 
do crossrecognize  the other HLA allele, interaction with po- 
sition 173 does not appear to be critical to the overall recog- 
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Figure 4.  TCR o~ and B chains of A24-selected CTL clones and their crossrecognition of Cw3. The 26 CTL clones are listed on the vertical axis. 
For each clone, the in-frame TCR ~  transcript  encoding the key residues at the VDJ junction (6) was considered to encode the functional TCR 
chain. For CTL clones A24/PEFI, 2, 4, 5, and 8, a FACS  |  staining with the anti-V~10 mAb B21.5 (52) was performed to confirm the ~ transcript 
assignment.  The deduced amino acid sequences of the junctional and hypervariable regions, putatively CDR3-1ike, are reported (in single-letter amino 
acid code) according to reference 6. The presumed Ig-like loops, designated CDR3 for convenience, are putatively CDR3-1ike, are reported (in single- 
letter amino acid code) according to reference 6. The presumed Ig-like loops, designated CDR3 for convenience, are putatively supported by two frame- 
work branches (FW), which are also reported here. The key Cys residue is at positions 90 and 92 in the c~ and/~ chains, respectively. The V~, VjS, 
Jc~, and J~ segments are also reported (see Fig. 3 for references). Regions of the TCR c~ or B chains expressed by the A24-selected CTL clones that 
differ from those expressed by Cw3-selected CTL clones were boxed. The ~  transcript  can be unambiguously assessed to encode the functional c~ 
chain, i.e., paired with the/~ chain to form a heterodimer specific for the HLA-A24 peptide-H-2K  d complex, only when a second, out-of-frame tran- 
script was also detected (15, 53). An out-of-frame ot transcript  was found in CTL clones A24/12.2, PEF4, A3/H2R2, H2R5, 72.2, and 332/2A, 
and a second o~ transcript, in-frame at the V-J  junction, was found in CTL clones A24/I0.1  and 322/1K. However, for the latter two and the remaining 
CTL clones, the ol transcripts reported here are likely to encode the functional c~ chains because of their structural homology with the unambiguously 
assigned ones. All CTL clones recognize the HLA-A24 170-179 antigenic site ([]). Level of crossrecognition  of the Cw3 170-179 antigenic site is 
indicated:  (r-I) recognition of Cw3 as well as that of A24;  (k~) intermediate  recognition;  or (I)  no recognition.  Clones that were not tested for 
recognition of Cw3 are indicated (NT). Clones A3/74.1 and 72.2 were tested for recognition of P815-Cw3 and A3 transfectant cells and for recognition 
of Cw3 and A24 170-182 peptides, and clone A3/72.2 was further tested for recognition of Cw3 and A24 170-179 peptides. Clones A24/10.1 and 
A24/12.2 were tested for recognition  of P815-A24 and Cw3 transfectant cells, and for recognition  of Cw3 and A24 170-182 peptides, and clone A24/10.1 
was further tested for recognition of Cw3 and A24 170-179 peptides. Clones A24/PEF1,  PEF2, PEF4, PEF8, and PEG2 were tested for recognition 
of Cw3 and A24 170-179 peptides. Clones 223/5, 223/14, 223/27, 332/1K, 332/2A, 332/2G, A2/25, and A3/63 were tested for recognition of P815- 
Cw3 and A24 transfectant cells and for recognition of Cw3 and A24 170-179 peptides. E/T ratios or peptide concentrations were titrated to evaluate 
the relative recognition of transfectants or peptides, respectively. 
nition of the peptide/MHC complex. Therefore,  regions of 
the TCRs expressed by these CTLs, if any, contacting this 
residue cannot be deduced from this structure-function anal- 
5,sis. In contrast, the comparison of the noncrossreactive CTL 
clones, strictly specific for either Cw3 or A24, provides evi- 
dence that the TCR ~ junctional regions expressed by these 
CTL interact with position 173 in the amino-terminal part 
of the HLA peptides. 
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Figure  S.  Crossrecognition  of Cw3 by a set ofA24-selected CTL clones. 
Two A24-selected CTL clones, 332/1K and A3/63,  were tested for recog- 
nition either of P815 cells transfected  with the HLA-Cw3 (O) or A24 
(O) genes (left); or of P815 (H-2  d) target cells pulsed with HLA-Cw3 (O) 
or A24 (O) 170-179 peptides (right).  Lysis of control P815 cells without 
peptide is also  shown  (dashed lines). 
Three  groups have independently proposed  a model  in 
which the ot and B CDR3  loops of the TCR would pri- 
marily interact with the antigenic peptide, whereas the CDR1 
and 2 would contact the MHC restriction element (6, 20, 21). 
These models were essentially based on the much higher vari- 
ability of the CDR3 and antigenic peptides, when compared 
with the CDR1,  2,  and MHC molecules,  respectively. 
Experimental evidence supporting this model, and in par- 
ticular that TCR CDR3 loops were critical for recognition 
of the antigenic peptide,  has been provided  in various class 
II MHC-restricted  systems.  Conclusions were mainly based 
on the differences of peptide fine specificities displayed by T 
cells bearing TCRs, either natural variants (22-25) or genet- 
ically engineered  (26, 27), that differed at a single position 
in either  of the CDR3  loops. 
Of the four studies in which the effect of a single substitu- 
tion in the antigenic peptide was analyzed,  two suggest that 
both the CDR3 ce and/~ are critical for recognition of the 
same residue in the carboxy terminus either of the X repressor 
(23) or of the cytochrome c (27) peptides.  Two others  sug- 
gest that the CDR3 ce interacts with a residue in the carboxy- 
terminal part or in the amino-terminal part of the myoglobin 
(22)  or  hemagglutinin (24)  peptides,  respectively. 
The orientations  may indeed differ from case to case. Al- 
ternatively, elements other than the TCR sequences,  which 
vary from cell to cell,  may also affect recognition patterns, 
as seems  to be the case in the present  study among Cw3- 
selected CTL clones tested for crossrecognition of A24. These 
include level of TCR, level of adhesion molecules, sensitivity 
of activation pathways, etc. In addition, correlations between 
Figure  6.  Direct sequencing  of TCR junctional regions expressed  in 
vivo by PELs from immune mice. The PELs originating from DBA/2 
mice immunized with P815-Cw3  or P815-A24 transfectant cells (two in- 
dividual mice for each antigen)  were purified by passage over nylon wool. 
The RNA  was extracted  from each of the four PEL samples, from the 
CTL clones Cw3/1.1,  Cas7, and A24/12.2, and from normal DBA/2 lymph 
nodes.  After cDNA synthesis,  the V310-J/81.2  junctional  regions were 
amplified by PCR using a combination of V310 and J31.2 primers.  The 
noncoding strand of each double-stranded  PCR product was directly se- 
quenced using the antisense JB1.2 primer. The four samples (A, normal 
lymph nodes;  B, CTL clone Cw3/1.1;  C, anti-A24 PELs from one in- 
dividual mouse; D, anti-Cw3 PELs from one individual mouse) were loaded 
on the same sequencing gel in the GATC order. The sequences  obtained 
from the other two animals gave similar results (not shown). In a second 
experiment, the VB10-JB1.4 junctional regions were amplified  by PCR 
using a pair of VB10-JB1.4 primers, and were sequenced with the andsense 
JB1.4 primer. The four samples (E, CTL done Cw3/Cas7; F, anti-Cw3 
PELs from one individual mouse; G, CTL clone A24/12.2; H, anti-A24 
PELs from one individual mouse) were loaded in the GATC order on the 
same sequendng gel as the VB10-JB1.2 sequences. The sequences obtained 
from the other two animals gave similar results (not shown). The sequenced 
noncoding strand of each PCR product  can be read from bottom to top 
(GATC from left to right). 
TCR primary structure and fine specificity  may not neces- 
sarily reflect only the direct interactions of the structures in- 
volved, but also differences in affinity provided by interac- 
tions at  other places. 
To settle  this issue,  an elegant approach,  which consists 
of analyzing the TCR repertoire in single chain TCR trans- 
genic mice immunized with variant peptides  substituted at 
a single position, has been reported recently  in the class II 
MHC-restricted  response to cytochrome c (28). The results 
indicate  that  both CDR3  ot and B  are critical  for peptide 
818  TCRs  Selected  by HLA-A24  in  the Context  of H-2K  d recognition, and that the CDR3 B would interact with the 
carboxy-terminal part of the peptide, whereas the CDR3 o~ 
would interact with the amino-terminal part of the peptide. 
We have adopted a similar approach to the class I MHC- 
restricted response to HLA-Cw3 with two modifications. First, 
we have immunized normal mice, which were free to adapt 
either of the TCR chains in response to the single amino 
acid substitution. Second, we have analyzed the TCR reper- 
toire used in vivo by harvesting PELs obtained from immune 
animals in order to confirm the findings obtained on T cell 
clones  isolated and grown in vitro. 
Altogether, our findings provide evidence that the TCR 
B junctional regions interact with the amino-terminal part 
of the HLA peptides presented by a class I MHC molecule. 
Notably, this orientation differs from that found in the class 
II MHC-restricted response  to cytochrome c (28).  Further 
experiments are required to determine whether the orienta- 
tion of the TCRs on the surface of MHC/peptide complexes 
varies according to the class of the MHC or to the nature 
of the peptide. 
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